BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 28596377)

  • 1. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
    Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
    Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.
    Lei X; Reheman A; Hou Y; Zhou H; Wang Y; Marshall AH; Liang C; Dai X; Li BX; Vanhoorelbeke K; Ni H
    Thromb Haemost; 2014 Feb; 111(2):279-89. PubMed ID: 24172860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The highly specific platelet glycoprotein (GP) VI agonist trowaglerix impaired collagen-induced platelet aggregation ex vivo through matrix metalloproteinase-dependent GPVI shedding.
    Chang CH; Chung CH; Kuo HL; Hsu CC; Huang TF
    J Thromb Haemost; 2008 Apr; 6(4):669-76. PubMed ID: 18221359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
    Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Snake venom metalloproteinases, crotarhagin and alborhagin, induce ectodomain shedding of the platelet collagen receptor, glycoprotein VI.
    Wijeyewickrema LC; Gardiner EE; Moroi M; Berndt MC; Andrews RK
    Thromb Haemost; 2007 Dec; 98(6):1285-90. PubMed ID: 18064326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice.
    Grüner S; Prostredna M; Koch M; Miura Y; Schulte V; Jung SM; Moroi M; Nieswandt B
    Blood; 2005 Feb; 105(4):1492-9. PubMed ID: 15507524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
    Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W
    Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin.
    Ahmed MU; Kaneva V; Loyau S; Nechipurenko D; Receveur N; Le Bris M; Janus-Bell E; Didelot M; Rauch A; Susen S; Chakfé N; Lanza F; Gardiner EE; Andrews RK; Panteleev M; Gachet C; Jandrot-Perrus M; Mangin PH
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2127-2142. PubMed ID: 32698684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An α
    Kuo YJ; Chen YR; Hsu CC; Peng HC; Huang TF
    J Thromb Haemost; 2017 Nov; 15(11):2230-2244. PubMed ID: 28815933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI.
    Pan G; Chang L; Zhang J; Liu Y; Hu L; Zhang S; Zhang J; Qiao J; Jakopin Ž; Hu H; Dong J; Ding Z
    Biochem Pharmacol; 2021 Jan; 183():114315. PubMed ID: 33152345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human platelet glycoprotein VI function is antagonized by monoclonal antibody-derived Fab fragments.
    Lecut C; Feeney LA; Kingsbury G; Hopkins J; Lanza F; Gachet C; Villeval JL; Jandrot-Perrus M
    J Thromb Haemost; 2003 Dec; 1(12):2653-62. PubMed ID: 14675102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Patients to Platelets and Back Again: Pharmacological Approaches to Glycoprotein VI, a Thrilling Antithrombotic Target with Minor Bleeding Risks.
    Martins Lima A; Martins Cavaco AC; Fraga-Silva RA; Eble JA; Stergiopulos N
    Thromb Haemost; 2019 Nov; 119(11):1720-1739. PubMed ID: 31564053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily.
    Jandrot-Perrus M; Busfield S; Lagrue AH; Xiong X; Debili N; Chickering T; Le Couedic JP; Goodearl A; Dussault B; Fraser C; Vainchenker W; Villeval JL
    Blood; 2000 Sep; 96(5):1798-807. PubMed ID: 10961879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor.
    Polgár J; Clemetson JM; Kehrel BE; Wiedemann M; Magnenat EM; Wells TN; Clemetson KJ
    J Biol Chem; 1997 May; 272(21):13576-83. PubMed ID: 9153205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox.
    Chang MC; Lin HK; Peng HC; Huang TF
    Blood; 1998 Mar; 91(5):1582-9. PubMed ID: 9473223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats.
    Li H; Lockyer S; Concepcion A; Gong X; Takizawa H; Guertin M; Matsumoto Y; Kambayashi J; Tandon NN; Liu Y
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1199-205. PubMed ID: 17322098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation.
    Moraes LA; Spyridon M; Kaiser WJ; Jones CI; Sage T; Atherton RE; Gibbins JM
    J Thromb Haemost; 2010 Mar; 8(3):577-87. PubMed ID: 20040043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct contributions of glycoprotein VI and alpha(2)beta(1) integrin to the induction of platelet protein tyrosine phosphorylation and aggregation.
    Kamiguti AS; Theakston RD; Watson SP; Bon C; Laing GD; Zuzel M
    Arch Biochem Biophys; 2000 Feb; 374(2):356-62. PubMed ID: 10666318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet effects of the CEACAM1-derived peptide QDTT.
    Ye Y; Leng M; Chai S; Yang L; Ren L; Wan W; Wang H; Li L; Li C; Meng Z
    Platelets; 2024 Dec; 35(1):2308635. PubMed ID: 38345065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.